ASX-listed (code ‘AYA’) well being tech firm Artrya has formally opened its plush new places of work on Hay Avenue in West Perth.
West Australian Deputy Premier Roger Prepare dinner and Chief Scientist Prof Peter Klinken have been each available to do the honours, along with co-founders CEO John Barrington AM and John Konstantopoulos.
Final November, the corporate listed on the Australian inventory market elevating A$40M, on an imputed market capitalisation of $106M.
Established in 2019, the corporate is pioneering synthetic intelligence to enhance cardiovascular care. Coronary artery illness is the main reason behind dying in Australia, but, as John Barrington stated on the workplace opening, “…diagnostic strategies for this illness have remained unchanged for practically 50 years.”
Artyra works alongside clinicians to enhance prognosis of coronary heart illness. It goals to develop an outline of sufferers most in danger. Treating points early can stop severe sickness, and dying.
Coronary heart illness is the number one killer of people on the planet (WHO, 2019).
“The staff has developed deep-learning algorithms that streamlines how medical care is being delivered,” stated John.
John additionally acknowledged the necessary growth companions who’ve been instrumental on this work: Envision Medical Imaging, Harry Perkins Institute of Medical Analysis, Monash Coronary heart and the College of Ottawa Institute.
The corporate now employs greater than 40 folks in West Perth and abroad.
Final month, Artyra appointed a brand new non-executive director Dr Jacque Sokolov to the board. He’s additionally chair and president of Artrya USA Inc, and chairs the corporate’s Medical Advisory Board. Over the course of his profession, Dr Sokolov has suggested US firms and authorities entities, together with the White Home underneath 4 presidents, Senate and Home committees.
In June, the corporate had a setback in its registration for FDA approval within the US. Their AI-driven product Salix Coronary Anatomy (SCA) didn’t get clearance from the US Meals and Drug Administration. Nonetheless, Salix is already listed on the Australian Register of Therapeutic Items (ID 347719), with business launch of SCA deliberate for this new monetary yr.
On the time, it was reported that Artrya had a wholesome financial institution stability, with money at name and on deposit of round $36 million.